Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05497206 · ClinicalTrials.gov registry record · NA
ROSA® Hip System THA PMCF
A NA study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05497206 is a NA study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 12 participants.
The verdict
NCT05497206, a NA study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study is a Prospective, Multicenter, Single-Arm, Cohort post-market study to evaluate the accuracy of acetabular implant position using the robotic-arm surgical assistant (ROSA® Hip System).
Interventions
- DEVICE One of the following hip implants may be used within this arm of the study: G7 Acetabular System, Taperloc Complete System, Avenir and Avenir Complete Systems, and Echo Bi-Metric System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-06-05 |
| Est. Completion | 2024-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05497206
The ClinicalTrials.gov registry entry for NCT05497206 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which One of the following hip implants may be used within this arm of the study: G7 Acetabular System, Taperloc Complete System, Avenir and Avenir Complete Systems, and Echo Bi-Metric System is the first listed.
NCT05497206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05497206 about?
NCT05497206 is a clinical study titled "ROSA® Hip System THA PMCF". This study is a Prospective, Multicenter, Single-Arm, Cohort post-market study to evaluate the accuracy of acetabular implant position using the robotic-arm surgical assistant (ROSA® Hip System).
What is the current status of trial NCT05497206?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2024-06-05. Estimated completion is 2024-12-20.
What interventions are being tested in trial NCT05497206?
The interventions under investigation include: One of the following hip implants may be used within this arm of the study: G7 Acetabular System, Taperloc Complete System, Avenir and Avenir Complete Systems, and Echo Bi-Metric System (DEVICE).
Who is sponsoring clinical trial NCT05497206?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.